Table 46.
Pharmacologic support utilized in cases reported to the Registry in 2012
| Pharmacologic support | 2012 N (%) |
|---|---|
| Benzodiazepines | 1,242 (57) |
| Antipsychotics | 205 (9) |
| Vasopressors | 198 (9) |
| Anticonvulsants | 113 (5) |
| Glucose >5 % | 83 (4) |
| Opioids | 83 (4) |
| Steroids | 39 (2) |
| Albuterol and other bronchodilators | 35 (2) |
| Neuromuscular blockers | 26 (1) |
| Beta blockers | 17 (1) |
| Antihypertensives | 16 (1) |
| Antiarrhythmics | 13 (1) |
| Clonidine | 13 (1) |
| Phenobarbital | 8 (0) |
| Vasodilators | 8 (0) |
| Antiemetics | 6 (0) |
| Propofol | 5 (0) |
| Totala | 2,172 |
aOnly support used more than five specific times were included in the above table. The total number of times “Pharmacologic Support” was used, however, was left intact. Often single entries were agents that should have been included only as antidote (i.e., naloxone) and not indicated as used for pharmacologic support